Drugs News and Research

RSS

Poll: Vast majority of older adults think health insurers should cover obesity medications

The vast majority of older adults – 83% -- think health insurers should cover medications that can help people with obesity manage their weight, a new poll of people age 50 to 80 finds.

13 Dec 2023

Developing a virtual twin for personalized cancer treatment with CAR-T cell therapy

In recent years, cancer immunotherapies have established themselves as a further pillar of medical oncology alongside traditional treatment options (surgery, radiotherapy and chemotherapy).

13 Dec 2023

Infective endocarditis deaths spike among young adults, research shows

Death rates related to infective endocarditis declined in most adults across the U.S. within the last two decades, yet accelerated among young adults ages 25 to 44 years old, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.

13 Dec 2023

As foundation for ‘excited delirium’ diagnosis cracks, fallout spreads

When Angelo Quinto's family learned that officials blamed his 2020 death on "excited delirium," a term they had never heard before, they couldn't believe it. To them, it was obvious the science behind the diagnosis wasn't real.

13 Dec 2023

Protective genetic variant shields Black Americans from kidney disease risk

Many Black Americans who are thought to have a high risk of developing kidney disease possess a protective genetic variant that nullifies the extra risk, a new study from Columbia researchers has found.

12 Dec 2023

AI model detects atrial fibrillation risk based on subtle ECG variations

A new artificial intelligence (AI) model designed by Scripps Research scientists could help clinicians better screen patients for atrial fibrillation (or AFib) - an irregular, fast heartbeat that is associated with stroke and heart failure.

12 Dec 2023

Study highlights the necessity to refine the design of randomized cancer drugs trials in China

More than one-eighth of the randomized trials of cancer drugs seeking regulatory approval in China in recent years used inappropriate controls to test the effectiveness and safety of the drugs, according to a new study published December 12th in the open access journal PLOS Medicine by Professor Xiaodong Guan of Peking University, China, and colleagues.

12 Dec 2023

Vegetarian diet linked to lower risk of insomnia, study suggests

Study reveals that following a vegetarian diet may reduce the risk of insomnia, particularly in men, potentially due to higher intakes of healthful plant-based foods and lower consumption of animal products.

12 Dec 2023

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Most patients with Type 2 diabetes will end up needing to add a second-line medication after metformin - the go-to primary drug for glucose management - to control their blood sugar levels.

12 Dec 2023

Gavi commits more than US$1.8 billion to support vaccine production in Africa

Gavi, the vaccine alliance, says it has committed more than US$1.8 billion to support vaccine production in Africa, a move that could bolster the continent’s efforts to address historical dependence on imported vaccines and establish its own robust biotechnology sector.

12 Dec 2023

Jena scientist receives grant for research on mitochondrial and neurodegenerative disease treatments

Dr. Kanstantsin Siniuk, postdoctoral researcher in the project group of Dr. Helmut Pospiech at the Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) Jena, has secured a 96,000 euro grant from the BMBF's GO-Bio initial program for his pioneering project on mitochondrial and neurodegenerative disease treatments.

12 Dec 2023

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

The current class of anti-obesity drugs is proving remarkably effective at removing excess pounds. However, a phase 3 randomized clinical trial led by researchers at Weill Cornell Medicine and NewYork-Presbyterian found that people who stopped taking the medication regained much of that weight within a year.

11 Dec 2023

Personalized treatment for leukemia results in longer life and fewer side effects

Personalized treatment for the most common form of adult leukemia helps patients survive for longer and stay in remission, a phase III trial has found.

11 Dec 2023

UMSOM receives $29 million research award to improve health outcomes in people who inject opioid drugs

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that the school will receive a $29 million research award over four years from the National Institutes of Health to lead a multicenter trial that aims to improve health outcomes in people who inject opioid drugs and are hospitalized with infectious complications of their drug use.

11 Dec 2023

Research uncovers potential treatment target for rare, genetic type of epilepsy

Researchers at the Francis Crick Institute, UCL and MSD have identified a potential treatment target for a genetic type of epilepsy.

11 Dec 2023

Second-line diabetes drugs safe for babies? New study offers reassurance

Infants born to women with pre-gestational type 2 diabetes who take second-line non-insulin antidiabetic medications (ADMs) during pregnancy are at no higher risk of major congenital malformations (MCMs) than infants born to those who take insulin, according to a new study led by Harvard T.H. Chan School of Public Health.

11 Dec 2023

Experienced meditators can voluntarily modulate their state of consciousness, study reveals

A study reveals that experienced meditators are able to voluntarily modulate their state of consciousness during meditation, i.e. they have the unusual ability, without the use of drugs, to induce a momentary void of consciousness during cessations through large-scale modulation of brain activity.

11 Dec 2023

New combinations and targeted therapies for acute myeloid leukemia on the horizon

The treatment landscape for acute myeloid leukemia (AML) is evolving rapidly, as research discoveries at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and other academic cancer centers advance new, more effective therapies for this aggressive blood cancer.

11 Dec 2023

CAR-T cell therapy remains viable for patients in lymphoma remission, study finds

A study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that CAR-T immunotherapy remains a viable option for patients who have lymphoma that goes into remission before the cell therapy begins.

11 Dec 2023

Mindfulness could hold the key to mitigating relapse in women with opioid use disorder

Mindfulness-Oriented Recovery Enhancement (MORE) - a behavioral intervention that integrates training in mindfulness, emotion regulation strategies and savoring of natural rewards - could hold the key to mitigating relapse in women undergoing medically assisted opioid use disorder treatment, a Rutgers study found.

11 Dec 2023

Drugs News and Research

Poll: Vast majority of older adults think health insurers should cover obesity medications

Developing a virtual twin for personalized cancer treatment with CAR-T cell therapy

Infective endocarditis deaths spike among young adults, research shows

As foundation for ‘excited delirium’ diagnosis cracks, fallout spreads

Protective genetic variant shields Black Americans from kidney disease risk

AI model detects atrial fibrillation risk based on subtle ECG variations

Study highlights the necessity to refine the design of randomized cancer drugs trials in China

Vegetarian diet linked to lower risk of insomnia, study suggests

Adherence to second-line drugs for Type 2 diabetes can be hit or miss, study reports

Gavi commits more than US$1.8 billion to support vaccine production in Africa

Jena scientist receives grant for research on mitochondrial and neurodegenerative disease treatments

Tirzepatide maintains weight loss and improves cardiometabolic health in SURMOUNT-4 trial

Personalized treatment for leukemia results in longer life and fewer side effects

UMSOM receives $29 million research award to improve health outcomes in people who inject opioid drugs

Research uncovers potential treatment target for rare, genetic type of epilepsy

Second-line diabetes drugs safe for babies? New study offers reassurance

Experienced meditators can voluntarily modulate their state of consciousness, study reveals

New combinations and targeted therapies for acute myeloid leukemia on the horizon

CAR-T cell therapy remains viable for patients in lymphoma remission, study finds

Mindfulness could hold the key to mitigating relapse in women with opioid use disorder

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News